Somatorelin
 | This article relies largely or entirely on a single source. (October 2014) |
| Clinical data | |
|---|---|
| Trade names | GHRH Ferring |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C215H358N72O66S |
| Molar mass | 5039.73 g·mol−1 |
  (what is this?) (verify) | |
Somatorelin is a diagnostic agent for determining growth hormone deficiency.[1] It is a recombinant version of growth hormone-releasing hormone (GHRH).
Somatorelin has been used to study hormone deficiency (particularly growth hormone deficiency), cognitive impairment, sleep disorders, and aging.[2]
See also
[edit]References
[edit]- ^ "GHRH Ferring". Retrieved 2009-02-25.
- ^ "Somatorelin". pubchem.ncbi.nlm.nih.gov. PubChem. Retrieved 17 January 2023.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |